Last 12 months
Inside the activity.
0 purchase rows · 53 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 21 |
| Jan 2026 | 0 | 11 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 3, 2024 00:52 UTC |
Korsanos AntoniaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001353 · form4.xml · derivative · entry 4 Korsanos Antonia · CIK 0001825242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 00:52 UTC |
Korsanos AntoniaDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001353 · form4.xml · derivative · entry 3 Korsanos Antonia · CIK 0001825242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,835 Underlying: Common Stock · 1,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents vesting of one-third of the restricted stock units granted on December 11, 2023. The balance of the award is scheduled to vest in two substantially equal installments on October 1, 2025 and October 1, 2026. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 00:52 UTC |
Korsanos AntoniaDirector
|
Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001353 · form4.xml · nonDerivative · entry 1 Korsanos Antonia · CIK 0001825242 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2024 Filed Sep 5, 2024 00:59 UTC |
Sottile JamesExec VP, CLO & Corp Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001177 · form4.xml · derivative · entry 3 Sottile James · CIK 0001751535 · Exec VP, CLO & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents vesting of restricted stock units granted on September 2, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents vesting of restricted stock units granted on September 2, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents vesting of restricted stock units granted on September 2, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| August 31, 2024 Filed Sep 5, 2024 00:59 UTC |
Sottile JamesExec VP, CLO & Corp Sec
|
Tax withholdingCommon Stock | 1,602 | $108.88 | $174,425.76 |
DisclosureSEC source: 0000950157-24-001177 · form4.xml · nonDerivative · entry 2 Sottile James · CIK 0001751535 · Exec VP, CLO & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,600 F1 · price: Represents the satisfaction of tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| August 31, 2024 Filed Sep 5, 2024 00:59 UTC |
Sottile JamesExec VP, CLO & Corp Sec
|
Exercise / conversionCommon Stock | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001177 · form4.xml · nonDerivative · entry 1 Sottile James · CIK 0001751535 · Exec VP, CLO & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:33 UTC |
Chow OliverEVP, CFO & Treas
|
Exercise / conversionRestricted Stock Units · Derivative | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001132 · form4.xml · derivative · entry 3 Chow Oliver · CIK 0001991805 · EVP, CFO & Treas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Underlying: Common Stock · 878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of one-third of restricted stock units granted on August 30, 2023. The balance of the award is scheduled to vest in equal installments on each of August 25, 2025 and August 25, 2026. Each restricted stock unit converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of one-third of restricted stock units granted on August 30, 2023. The balance of the award is scheduled to vest in equal installments on each of August 25, 2025 and August 25, 2026. Each restricted stock unit converts into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of one-third of restricted stock units granted on August 30, 2023. The balance of the award is scheduled to vest in equal installments on each of August 25, 2025 and August 25, 2026. Each restricted stock unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:33 UTC |
Chow OliverEVP, CFO & Treas
|
Tax withholdingCommon Stock | 346 | $109.28 | $37,810.88 |
DisclosureSEC source: 0000950157-24-001132 · form4.xml · nonDerivative · entry 2 Chow Oliver · CIK 0001991805 · EVP, CFO & Treas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,479 F1 · price: Represents the satisfaction of tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| August 25, 2024 Filed Aug 27, 2024 21:33 UTC |
Chow OliverEVP, CFO & Treas
|
Exercise / conversionCommon Stock | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-001132 · form4.xml · nonDerivative · entry 1 Chow Oliver · CIK 0001991805 · EVP, CFO & Treas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:46 UTC |
Regan Michael JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000880 · form4.xml · derivative · entry 2 Regan Michael J · CIK 0001294847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:46 UTC |
Regan Michael JDirector
|
Exercise / conversionCommon Stock | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000880 · form4.xml · nonDerivative · entry 1 Regan Michael J · CIK 0001294847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:44 UTC |
Vullo Maria TDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000879 · form4.xml · derivative · entry 2 Vullo Maria T · CIK 0001778479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:44 UTC |
Vullo Maria TDirector
|
Exercise / conversionCommon Stock | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000879 · form4.xml · nonDerivative · entry 1 Vullo Maria T · CIK 0001778479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:42 UTC |
YOUNGBLOOD DR KNEELANDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000878 · form4.xml · derivative · entry 2 YOUNGBLOOD DR KNEELAND · CIK 0001137820 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents vesting of one-fourth of restricted stock units granted on June 10, 2020. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 10, 2024 Filed Jun 10, 2024 22:42 UTC |
YOUNGBLOOD DR KNEELANDDirector
|
Exercise / conversionCommon Stock | 2,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000878 · form4.xml · nonDerivative · entry 1 YOUNGBLOOD DR KNEELAND · CIK 0001137820 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:59 UTC |
Vullo Maria TDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000866 · form4.xml · derivative · entry 2 Vullo Maria T · CIK 0001778479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:59 UTC |
Vullo Maria TDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000866 · form4.xml · nonDerivative · entry 1 Vullo Maria T · CIK 0001778479 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:57 UTC |
Regan Michael JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000865 · form4.xml · derivative · entry 2 Regan Michael J · CIK 0001294847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:57 UTC |
Regan Michael JDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000865 · form4.xml · nonDerivative · entry 1 Regan Michael J · CIK 0001294847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:55 UTC |
Throsby TimothyDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000864 · form4.xml · derivative · entry 3 Throsby Timothy · CIK 0001827186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:55 UTC |
Throsby TimothyDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000864 · form4.xml · nonDerivative · entry 1 Throsby Timothy · CIK 0001827186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:54 UTC |
YOUNGBLOOD DR KNEELANDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000863 · form4.xml · derivative · entry 3 YOUNGBLOOD DR KNEELAND · CIK 0001137820 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:54 UTC |
YOUNGBLOOD DR KNEELANDDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000863 · form4.xml · nonDerivative · entry 1 YOUNGBLOOD DR KNEELAND · CIK 0001137820 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:52 UTC |
SHANKS VIRGINIA EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000862 · form4.xml · derivative · entry 3 SHANKS VIRGINIA E · CIK 0001269955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:52 UTC |
SHANKS VIRGINIA EDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000862 · form4.xml · nonDerivative · entry 1 SHANKS VIRGINIA E · CIK 0001269955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,160 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:50 UTC |
Morro Stephen WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000861 · form4.xml · derivative · entry 3 Morro Stephen W · CIK 0001318210 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:50 UTC |
Morro Stephen WDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000861 · form4.xml · nonDerivative · entry 1 Morro Stephen W · CIK 0001318210 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:44 UTC |
McLennan HamishDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000860 · form4.xml · derivative · entry 5 McLennan Hamish · CIK 0001830349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. F4 · derivative.expiration_date: Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 20:44 UTC |
McLennan HamishDirector
|
Exercise / conversionCommon Stock | 3,320 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000860 · form4.xml · nonDerivative · entry 1 McLennan Hamish · CIK 0001830349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:09 UTC |
Marchetti MichaelDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000868 · form4.xml · derivative · entry 1 Marchetti Michael · CIK 0001304491 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:55 UTC |
Throsby TimothyDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000864 · form4.xml · derivative · entry 2 Throsby Timothy · CIK 0001827186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:54 UTC |
YOUNGBLOOD DR KNEELANDDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000863 · form4.xml · derivative · entry 2 YOUNGBLOOD DR KNEELAND · CIK 0001137820 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:52 UTC |
SHANKS VIRGINIA EDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000862 · form4.xml · derivative · entry 2 SHANKS VIRGINIA E · CIK 0001269955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:50 UTC |
Morro Stephen WDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000861 · form4.xml · derivative · entry 2 Morro Stephen W · CIK 0001318210 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F1 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:44 UTC |
McLennan HamishDirector
|
GrantRestricted Stock Units · Derivative | 2,159 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000860 · form4.xml · derivative · entry 4 McLennan Hamish · CIK 0001830349 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,159 Underlying: Common Stock · 2,159 shares Expires not disclosed F3 · derivative.exercise_price: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| May 17, 2024 Filed May 21, 2024 01:10 UTC |
Korsanos AntoniaDirector
|
PurchaseCommon Stock | 70 | $95.04 | $6,652.80 |
DisclosureSEC source: 0000950157-24-000782 · form4.xml · nonDerivative · entry 2 Korsanos Antonia · CIK 0001825242 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Child Disclosed balance after: 313 F1 · shares: The reporting person disclaims beneficial ownership of the shares held by her child, which underly Chess Depository Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Company that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depository Nominees Pty Limited, a subsidiary of ASX Limited, the company that operates the ASX. Each CDI represents one fully paid share of common stock. This report should not be deemed an admission that the reporting person is the beneficial owner of her child's shares for purposes of Section 16 or for any other purpose. F2 · price: Price converted from Australian dollars into U.S. Dollars based on an exchange rate of $1 AUD to $0.6693 USD. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:08 UTC |
Korsanos AntoniaDirector
|
PurchaseCommon Stock | 72 | $91.51 | $6,588.72 |
DisclosureSEC source: 0000950157-24-000748 · form4.xml · nonDerivative · entry 2 Korsanos Antonia · CIK 0001825242 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Child Disclosed balance after: 243 F1 · shares: The reporting person disclaims beneficial ownership of the shares held by her child, which underly Chess Depository Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Company that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depository Nominees Pty Limited, a subsidiary of ASX Limited, the company that operates the ASX. Each CDI represents one fully paid share of common stock. This report should not be deemed an admission that the reporting person is the beneficial owner of her child's shares for purposes of Section 16 or for any other purpose. F2 · price: Price converted from Australian dollars into U.S. Dollars based on an exchange rate of $1 AUD to $0.6607 USD. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
OtherRestricted Stock Units · Derivative | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · derivative · entry 6 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526 Underlying: Common Stock · 526 shares Expires not disclosed F3 · derivative.exercise_price: Represents the vesting of one-third of restricted stock units granted on May 13, 2022. The balance of the award is scheduled to vest on May 13, 2025. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F3 · derivative.exercise_date: Represents the vesting of one-third of restricted stock units granted on May 13, 2022. The balance of the award is scheduled to vest on May 13, 2025. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F3 · derivative.expiration_date: Represents the vesting of one-third of restricted stock units granted on May 13, 2022. The balance of the award is scheduled to vest on May 13, 2025. Each restricted stock unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 197 | $91.55 | $18,035.35 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · nonDerivative · entry 4 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,619 F1 · price: Represents the satisfaction of tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
OtherCommon Stock | 526 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · nonDerivative · entry 3 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,816 Read SEC document |
| May 12, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
OtherRestricted Stock Units · Derivative | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · derivative · entry 5 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 938 shares Expires not disclosed F2 · derivative.exercise_price: Represents the vesting of one-third of restricted stock units granted on May 12, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: Represents the vesting of one-third of restricted stock units granted on May 12, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. F2 · derivative.expiration_date: Represents the vesting of one-third of restricted stock units granted on May 12, 2021. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis. Read SEC document |
| May 12, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 351 | $91.55 | $32,134.05 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · nonDerivative · entry 2 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,290 F1 · price: Represents the satisfaction of tax withholding obligations upon the vesting of restricted stock units. Read SEC document |
| May 12, 2024 Filed May 14, 2024 20:06 UTC |
Kalabic VanjaSVP & Chief Accounting Officer
|
OtherCommon Stock | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000747 · form4.xml · nonDerivative · entry 1 Kalabic Vanja · CIK 0001991621 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,641 Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
GrantRestricted Stock Units · Derivative | 9,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 13 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,770 Underlying: Common Stock · 9,770 shares Expires not disclosed F10 · derivative.exercise_price: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. F10 · derivative.exercise_date: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. F10 · derivative.expiration_date: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
GrantRestricted Stock Units · Derivative | 9,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 12 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,770 Underlying: Common Stock · 9,770 shares Expires not disclosed F9 · derivative.exercise_price: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. F9 · derivative.exercise_date: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. F9 · derivative.expiration_date: The restricted stock units are scheduled to cliff vest on March 20, 2027, contingent upon the achievement of a performance goal. If the performance goal is not met by December 31, 2026, all restricted stock units are forfeited. Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
GrantRestricted Stock Units · Derivative | 19,540 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 11 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,540 Underlying: Common Stock · 19,540 shares Expires not disclosed F8 · derivative.exercise_price: The restricted stock units are scheduled to vest on March 20, 2025 (6,513 shares), March 20, 2026 (6,513 shares) and March 20, 2027 (6,514 shares). Each unit converts into a share of common stock on a one-for-one basis. F8 · derivative.exercise_date: The restricted stock units are scheduled to vest on March 20, 2025 (6,513 shares), March 20, 2026 (6,513 shares) and March 20, 2027 (6,514 shares). Each unit converts into a share of common stock on a one-for-one basis. F8 · derivative.expiration_date: The restricted stock units are scheduled to vest on March 20, 2025 (6,513 shares), March 20, 2026 (6,513 shares) and March 20, 2027 (6,514 shares). Each unit converts into a share of common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 11,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 10 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,733 Underlying: Common Stock · 11,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Represents the vesting of one-third of restricted stock units granted on March 24, 2023. The balance of the award is scheduled to vest in two substantially installments on March 20, 2025 (11,366) and March 20, 2026 (11,367). Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. F7 · derivative.exercise_date: Represents the vesting of one-third of restricted stock units granted on March 24, 2023. The balance of the award is scheduled to vest in two substantially installments on March 20, 2025 (11,366) and March 20, 2026 (11,367). Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. F7 · derivative.expiration_date: Represents the vesting of one-third of restricted stock units granted on March 24, 2023. The balance of the award is scheduled to vest in two substantially installments on March 20, 2025 (11,366) and March 20, 2026 (11,367). Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 9 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,200 Underlying: Common Stock · 4,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Represents the vesting of one-third of restricted stock units granted on March 25, 2022. The balance of the award is scheduled to vest on March 20, 2025. Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. F6 · derivative.exercise_date: Represents the vesting of one-third of restricted stock units granted on March 25, 2022. The balance of the award is scheduled to vest on March 20, 2025. Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. F6 · derivative.expiration_date: Represents the vesting of one-third of restricted stock units granted on March 25, 2022. The balance of the award is scheduled to vest on March 20, 2025. Each restricted stock unit converts into a share of class A common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,683 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 8 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 93% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. F5 · derivative.exercise_date: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 93% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. F5 · derivative.expiration_date: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 93% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. Read SEC document |
| March 20, 2024 Filed Mar 23, 2024 01:04 UTC |
Wilson Matthew R.President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,186 | $0.00 | $0.00 |
DisclosureSEC source: 0000950157-24-000507 · form4.xml · derivative · entry 7 Wilson Matthew R. · CIK 0001803574 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 100% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. F4 · derivative.exercise_date: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 100% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. F4 · derivative.expiration_date: Represents the cliff vesting of restricted stock units granted on March 22, 2021 subject to the achievement of performance criteria over a three-year period. Based on the level of achievement, 100% of the RSUs vested and converted into a share of class A common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.